Key result
Simultaneous TAVR and EVAR is feasible and safe for concurrent severe AS and AAA.
Why the study?
Simultaneous TAVR and EVAR is a technically feasible option in high-risk patients, but clinical experience and data remain limited.
Simultaneous EVAR and TAVR is technically feasible and is a reliable option in high‐risk patients.
No takes yet. Share an insight, caveat, or question.
Schizas et al. (2021) conducted a review in Severe symptomatic aortic valve stenosis and abdominal aortic aneurysm (n=17). Simultaneous Transcatheter Aortic Valve Replacement (TAVR) and Endovascular Aneurysm Repair (EVAR) was evaluated on Feasibility and safety of simultaneous EVAR and TAVR. Simultaneous TAVR and EVAR is technically feasible and a reliable treatment option for high-risk patients with concurrent severe symptomatic aortic valve stenosis and abdominal aortic aneurysms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: